<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>retinal neovascularization &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/retinal-neovascularization/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 12:38:09 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>retinal neovascularization &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>IL-6 Trans-Signaling: Key Driver of Retinal Neovascularization?</title>
		<link>https://bioengineer.org/il-6-trans-signaling-key-driver-of-retinal-neovascularization/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 12:37:43 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Angiogenesis therapy** **Kısa açıklama:** 1. **IL-6 trans-signaling:** Makalenin ana konusu ve araştırmanın temel odağı. 2. **Retinal neovascularization:** Çalışmanın incelediği pat]]></category>
		<category><![CDATA[diabetic retinopathy]]></category>
		<category><![CDATA[İçeriğe uygun 5 etiket: **IL-6 trans-signaling]]></category>
		<category><![CDATA[IL-6 trans-signaling]]></category>
		<category><![CDATA[ocular inflammation]]></category>
		<category><![CDATA[retinal neovascularization]]></category>
		<category><![CDATA[targeted therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/il-6-trans-signaling-key-driver-of-retinal-neovascularization/</guid>

					<description><![CDATA[In the realm of retinal research, a groundbreaking study has emerged that highlights the intricate relationship between IL-6 trans-signaling and retinal neovascularization. This study, conducted by a team of researchers led by Jung et al., sheds light on a critical but often overlooked factor in the pathology of retinal diseases. Retinal neovascularization is a complex [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318323</post-id>	</item>
	</channel>
</rss>
